Burnham receives skin flora research grant

Carey-Ann Burnham, PhD, of Washington University School of Medicine in St. Louis, has received a one-year, $58,750 grant from The Foundation for Barnes-Jewish Hospital and the Washington University Institute of Clinical and Translational Sciences for research titled “Sequencing and Culture-Based Evaluation of Skin Flora Following Decolonization.”

Oh receives medical research grants

Stephen Oh, MD, PhD, assistant professor of medicine at Washington University School of Medicine in St. Louis, has received a Doris Duke Clinical Scientist Development Award and a Damon Runyon Clinical Investigator Award, both totaling $486,000, for research titled “Targeting Aberrant Signaling Pathways in Myeloproliferative Neoplasms.”
Study shows who benefits most from statins

Study shows who benefits most from statins

New research suggests that widely used statin therapy provides the most benefit to patients with the highest genetic risk of heart attack. Using a relatively straightforward genetic analysis, the researchers, including Nathan O. Stitziel, MD, PhD, assessed heart attack risk independently of the traditional risk factors.
Washington People: Melissa Hopkins

Washington People: Melissa Hopkins

Melissa Hopkins, assistant vice chancellor and assistant dean of facilities operations at the School of Medicine, excels at multi-tasking. At work, she oversees facilities engineering, design and construction, support services, business operations and protective services. At home, she and her husband have three children with plans to adopt three more. Further, she also shares custody of three children and has three adult sons from a previous marriage.

Immunobiology’s Shaw receives NIH grant

Andrey Shaw, MD, the Emil R. Unanue Professor of Immunobiology in the Department of Pathology and Immunology and director of the Division of Immunobiology at Washington University School of Medicine in St. Louis, has received a one-year, $84,583 grant from the National Institutes of Health (NIH) and Confluence Life Sciences Inc. for research titled “Development of TAK1 Inhibitors to Treat Pancreatic Cancer.”
View More Stories